News | January 26, 2021
Aurobindo Pharma gets approval for 3 products under PLI Scheme: ICICI Securities
Post approval under the PLI scheme, Aurobindo will become a very large player in anti-biotic space.
Post approval under the PLI scheme, Aurobindo will become a very large player in anti-biotic space.
Before joining Gland, Loomba was associated with Shalina Labs, Harman Finochem, Aurobindo Pharma, Sun Pharmaceuticals and Ranabaxy Laboratories.
Eugia Pharma Specialities restarts production at terminally sterilized product lines
IOL Chemicals and Pharmaceuticals’ product approved by CDE of NMPA, China
Trastuzumab biosimilar is a humanized monoclonal antibody for treating metastatic breast cancer
The product is expected to be launched in December 2023
The plant is yet to start commercial operations
The product is expected to be launched in FY25
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)
